Brendan L. Flannery, PhD
Affiliations: | Center Disease Control, Atlanta, GA, United States |
Area:
http://www.biomedexperts.com/Profile.bme/405697/Brendan_FlanneryWebsite:
http://www.hibaction.org/hibinitiative/flannery_b.phpGoogle:
"Brendan Flannery"Mean distance: 106866 (cluster 28) | S | N | B | C | P |
Parents
Sign in to add mentor| David Epel | research assistant | Hopkins Marine Station, Stanford University | ||
| Lee W. Riley | grad student | 2002 | UC Berkeley (ID Tree) | |
| (Urban epidemics of leptospirosis in Salvador, Brazil.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tenforde MW, Weber ZA, Yang DH, et al. (2024) Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023. The Journal of Infectious Diseases. 230: 141-151 |
| Sumner KM, Yadav R, Noble EK, et al. (2024) Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022. The Journal of Infectious Diseases. 230: 45-54 |
| Sandford R, Yadav R, Noble EK, et al. (2024) Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021-June 2022. Influenza and Other Respiratory Viruses. 18: e13339 |
| Boyce TG, Levine MZ, McClure DL, et al. (2024) Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Human Vaccines & Immunotherapeutics. 20: 2370087 |
| Chung JR, Shirk P, Gaglani M, et al. (2024) Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023. Influenza and Other Respiratory Viruses. 18: e13342 |
| Bi Q, Dickerman BA, Nguyen HQ, et al. (2024) Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection. The Journal of Infectious Diseases |
| King JP, Chung JR, Donahue JG, et al. (2024) Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period. Bmc Infectious Diseases. 24: 300 |
| Frutos AM, Price AM, Harker E, et al. (2024) Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States. Mmwr. Morbidity and Mortality Weekly Report. 73: 168-174 |
| Liu F, Gross FL, Joshi S, et al. (2024) Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines. Nature Communications. 15: 254 |
| Sandford R, Yadav R, Noble EK, et al. (2023) Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022. Medrxiv : the Preprint Server For Health Sciences |